Valuation: Guided Therapeutics, Inc.

Market Cap 28M 24.27M 22.75M 20.74M 39.03M 2.67B 39.65M 268M 105M 1.34B 105M 103M 4.46B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 30.87M 26.76M 25.09M 22.87M 43.04M 2.95B 43.73M 295M 115M 1.47B 116M 113M 4.92B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Current month-3.33%
1 month-3.33%
3 months+45.00%
6 months-6.45%
Current year-46.30%
1 week 0.24
Extreme 0.2401
0.29
1 month 0.24
Extreme 0.2401
0.3
Current year 0.17
Extreme 0.17
0.54
1 year 0.15
Extreme 0.15
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
3,200
Manager TitleAgeSince
Chief Executive Officer 70 05/03/2023
Chief Tech/Sci/R&D Officer 70 01/12/2010
Director TitleAgeSince
Director/Board Member 70 30/11/2016
Director/Board Member 76 09/04/2006
Chairman 67 30/09/2013
Date Insider Type Main position Quantity % Market Cap.
25/02/26 Others

Director

260 25.3411%
25/02/26 Option

Chairman

600,000 0.7177%
25/02/26 Fiscal year

Director

8,477,131 10.1402%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+48.72%+70.59% 28M
-1.18%+3.13%+24.82%+9.58% 223B
-0.92%+2.12%-0.89%-20.17% 145B
0.00%+6.95%-16.09%+31.78% 142B
+0.53%+8.27%-49.64%+1.29% 74.52B
-0.53%+4.04%+20.32%+16.56% 53.63B
+0.03%-0.51%-15.63%-17.27% 50.14B
+0.71%+5.80%+27.25%+17.68% 41.87B
-0.63%+3.38%+44.83%+41.78% 40.89B
+2.09%+5.05%-0.83%+3.07% 32.65B
Average +0.21%+3.54%+8.29%+15.49% 80.31B
Weighted average by Cap. -0.20%+3.83%+3.34%+7.96%

Financials

2024 2025
Net sales 7K 6.07K 5.69K 5.19K 9.76K 668K 9.91K 66.97K 26.15K 334K 26.28K 25.71K 1.12M 767K 665K 623K 568K 1.07M 73.2M 1.09M 7.34M 2.86M 36.64M 2.88M 2.82M 122M
Net income -2.42M -2.1M -1.96M -1.79M -3.37M -231M -3.42M -23.12M -9.03M -115M -9.07M -8.88M -385M -3.2M -2.77M -2.6M -2.37M -4.46M -305M -4.53M -30.58M -11.94M -153M -12M -11.74M -509M
Net Debt 1.77M 1.54M 1.44M 1.31M 2.47M 169M 2.51M 16.94M 6.62M 84.61M 6.65M 6.5M 282M 2.88M 2.49M 2.34M 2.13M 4.01M 274M 4.07M 27.52M 10.74M 137M 10.8M 10.56M 458M
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
13/08/26 US$0.2900 0.00% 3,162
  1. Stock Market
  2. Stocks
  3. GTHP Stock